P

Providence Therapeutics

64 employees

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

Basic info

Industry

biotechnology research

Sectors

cancer vaccines
Biotechnology
lipid nanoparticles
Therapeutics
Wellness
COVID-19 Vaccine
personalized vaccines
Health Care
mRNA therapeutics
biotech

Date founded

2015

Funding rounds raised

Total raised

$2.1M

from 1 investors over 1 rounds

P

Providence Therapeutics raised $2.1M on December 7, 2021

Investors: Bill & Melinda Gates Foundation

FAQ